As expected, we did not find indications that Id2 expression is prognostic between IDC-NST and ILC when analyzing several publicly available breast cancer datasets (TCGA, METABRIC, Michaut [29] and Metzger [30]) (Supplementary Fig. 8). The gene discussed is ID2; the disease is breast carcinoma.